Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pascal Finetti

Showing results (121-130 of 180) with videos related to

Pageof 18
Sort By:
NPJ Breast Cancer|January 19, 2022
Comparative transcriptional analyses of preclinical models and patient samples reveal MYC and RELA driven expression patterns that define the molecular landscape of IBCCharlotte Rypens, François Bertucci, Pascal Finetti, et al.
Journal of Translational Medicine|October 28, 2024
Whole-exome profiles of inflammatory breast cancer and pathological response to neoadjuvant chemotherapyFrançois Bertucci, Arnaud Guille, Florence Lerebours, et al.
Cellular and Molecular Gastroenterology and Hepatology|November 10, 2022
Axin1 Protects Colon Carcinogenesis by an Immune-Mediated EffectRomain Sanson, Silvia Luna Lazzara, David Cune, et al.
Molecular Cancer Therapeutics|May 9, 2022
Overcoming Resistance to Anti-Nectin-4 Antibody-Drug ConjugateOlivier Cabaud, Ludovic Berger, Emerence Crompot, et al.
Clinical Epigenetics|October 14, 2019
Epigenetic down-regulation of the HIST1 locus predicts better prognosis in acute myeloid leukemia with NPM1 mutationSylvain Garciaz, Lia N'guyen Dasi, Pascal Finetti, et al.
The Journal of Clinical Investigation|July 2, 2026
Tumor cell-derived extracellular vesicles foster the immunosuppressive landscape of pancreatic cancerZainab Hussain, Claudio Montenegro, Christopher Rovera, et al.
Cancers|October 23, 2020
Novel Therapeutic Insights in Dedifferentiated Liposarcoma: A Role for FGFR and MDM2 Dual TargetingBérengère Dadone-Montaudié, Audrey Laroche-Clary, Aline Mongis, et al.
British Journal of Haematology|October 1, 2010
ASXL1 mutation is associated with poor prognosis and acute transformation in chronic myelomonocytic leukaemiaVéronique Gelsi-Boyer, Virginie Trouplin, Julien Roquain, et al.
Journal of Translational Medicine|June 23, 2023
Clinical, pathological, and comprehensive molecular analysis of the uterine clear cell carcinoma: a retrospective national study from TMRG and GINECO networkElsa Nigon, Claudia Lefeuvre-Plesse, Alejandra Martinez, et al.
Science Advances|December 12, 2025
The extracellular matrix drives guanylate production and protects pancreatic cancer cells from oxaliplatin-induced DNA damageGeorgios Efthymiou, Eugénie Lohmann, Claudio Montenegro, et al.
Pageof 18

Showing results (121-130 of 180) with videos related to

Sort By:
Pageof 18
NPJ Breast Cancer|January 19, 2022
Comparative transcriptional analyses of preclinical models and patient samples reveal MYC and RELA driven expression patterns that define the molecular landscape of IBCCharlotte Rypens, François Bertucci, Pascal Finetti, et al.
Journal of Translational Medicine|October 28, 2024
Whole-exome profiles of inflammatory breast cancer and pathological response to neoadjuvant chemotherapyFrançois Bertucci, Arnaud Guille, Florence Lerebours, et al.
Cellular and Molecular Gastroenterology and Hepatology|November 10, 2022
Axin1 Protects Colon Carcinogenesis by an Immune-Mediated EffectRomain Sanson, Silvia Luna Lazzara, David Cune, et al.
Molecular Cancer Therapeutics|May 9, 2022
Overcoming Resistance to Anti-Nectin-4 Antibody-Drug ConjugateOlivier Cabaud, Ludovic Berger, Emerence Crompot, et al.
Clinical Epigenetics|October 14, 2019
Epigenetic down-regulation of the HIST1 locus predicts better prognosis in acute myeloid leukemia with NPM1 mutationSylvain Garciaz, Lia N'guyen Dasi, Pascal Finetti, et al.
The Journal of Clinical Investigation|July 2, 2026
Tumor cell-derived extracellular vesicles foster the immunosuppressive landscape of pancreatic cancerZainab Hussain, Claudio Montenegro, Christopher Rovera, et al.
Cancers|October 23, 2020
Novel Therapeutic Insights in Dedifferentiated Liposarcoma: A Role for FGFR and MDM2 Dual TargetingBérengère Dadone-Montaudié, Audrey Laroche-Clary, Aline Mongis, et al.
British Journal of Haematology|October 1, 2010
ASXL1 mutation is associated with poor prognosis and acute transformation in chronic myelomonocytic leukaemiaVéronique Gelsi-Boyer, Virginie Trouplin, Julien Roquain, et al.
Journal of Translational Medicine|June 23, 2023
Clinical, pathological, and comprehensive molecular analysis of the uterine clear cell carcinoma: a retrospective national study from TMRG and GINECO networkElsa Nigon, Claudia Lefeuvre-Plesse, Alejandra Martinez, et al.
Science Advances|December 12, 2025
The extracellular matrix drives guanylate production and protects pancreatic cancer cells from oxaliplatin-induced DNA damageGeorgios Efthymiou, Eugénie Lohmann, Claudio Montenegro, et al.
Pageof 18